Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 183 of 183 entries
View as:

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02757144 Org: User:
Start: 03/31/16 End: 02/28/17 Due: 02/28/18

Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients

Phase: N/A Priority: Normal
NCT ID: NCT06606093 Org: User:
Start: 09/23/24 End: 01/31/27 Due: 01/31/28

Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01636401 Org: User:
Start: 08/31/12 End: 05/31/13 Due: 05/31/14

Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06508645 Org: User:
Start: 01/10/22 End: 04/06/22 Due: 04/06/23

Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315

Phase: N/A Priority: Normal
NCT ID: NCT06592495 Org: User:
Start: 10/31/24 End: 10/31/25 Due: 10/31/26

Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy;

Phase: N/A Priority: Normal
NCT ID: NCT06062030 Org: User:
Start: 03/08/24 End: 06/28/24 Due: 06/28/25

To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003

Phase: N/A Priority: Normal
NCT ID: NCT04592835 Org: User:
Start: 10/19/20 End: 06/30/21 Due: 06/30/22

Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy

Phase: N/A Priority: Normal
NCT ID: NCT04294251 Org: User:
Start: 03/04/20 End: 08/10/21 Due: 08/10/22